Susan J. Clark
St. Vincent's Clinical School
Sydney, NSW 2052, Australia
Sydney, NSW 2052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 121 publications
Interplay of the 3D genome and epigenome in androgen-driven prostate cancer.
Journal: Epigenomics
Published: May 22, 2026
DNA methylation reprogramming in marsupial embryos is restricted to the extraembryonic lineage.
Journal: Nature communications
Published: December 16, 2025
DNA methylation estimates of immune cell abundance have prognostic potential in triple negative breast cancer.
Journal: Clinical epigenetics
Published: September 19, 2025
Isoform-specific single-cell perturb-seq reveals distinct functions of alternative promoters in drug response.
Journal: Nucleic acids research
Published: January 27, 2025
PPARγ acetylation governs mammary adenocarcinoma tumor growth via acetylated residues that determine DNA sequence-specific binding.
Journal: Oncogene
Published: October 30, 2024
Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial.
Journal: Molecular cancer
Published: September 24, 2024
Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancer.
Journal: BJUI compass
Published: August 14, 2024
Irreversible electroporation of localised prostate cancer downregulates immune suppression and induces systemic anti-tumour T-cell activation - IRE-IMMUNO study.
Journal: BJU international
Published: August 05, 2024
Anisotropic Skyrmion and Multi-q Spin Dynamics in Centrosymmetric Gd_{2}PdSi_{3}.
Journal: Physical review letters
Published: March 13, 2024
UHRF1 ubiquitin ligase activity supports the maintenance of low-density CpG methylation.
Journal: Nucleic acids research
Published: March 07, 2024
Last Updated: 09/26/2026